Pausing Endocrine Therapy for Pregnancy Safe in Early Breast Cancer

Study suggests no increased risk of cancer recurrence versus historical control

Related Keywords

San Antonio ,Texas ,United States ,Boston ,Massachusetts ,Dana Farber Cancer Institute ,America ,Mike Bassett ,Asia Pacific ,Ann Partridge ,Harvard Medical School ,Young ,San Antonio Breast Cancer ,Pregnancy Outcome ,Interrupting Therapy ,Women With Endocrine Responsive Breast Cancer ,North America ,Middle Eastern ,Antonio Breast Cancer ,